Aarben Biotech Private Limited
About Aarben Biotech Private Limited
Data last updated:
Aarben Biotech Private Limited was a private limited company based in Surat, Gujarat, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the retail trade segment of the trading and commerce sector. It was incorporated on 02 May 2011.
The company was registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24239GJ2011PTC065249.
The company had an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It was led by directors including Meena Pandey and Om Prakash Kushwaha.
Its last annual general meeting (AGM) was held on 30 September 2017, and its latest financial statements are for the year ended 31 March 2017. The registered office was at Surat, Gujarat.
As per the financials filed for FY 2017, the company reported a revenue of ₹44,780, a decline of 8% compared to the previous year. For the same year it recorded a net loss of ₹377 (net margin -0.8%) and EBITDA of ₹196 (EBITDA margin 0.4%). Revenue has declined at a compounded annual rate (CAGR) of 17% over three years.
Company details
Contact details
Aarben Biotech Private Limited's registered office is in Surat, Gujarat. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressAagam Navkar Appartment K – 204 2nd Floor Behind Sachin Railway Station, Kansad, Surat, Gujarat, India – 394235
- IndustryTrading, Retailers, Retail Trading
To see the full contact details of Aarben Biotech Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Aarben Biotech is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Aarben Biotech Private Limited, buy the company report.
Financials of Aarben Biotech Private Limited
FY 2017 filings availableAarben Biotech Private Limited reported revenue of ₹44,780 (down 8% YoY) for FY 2017.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 17% over three years, including a 8% fall in the latest year. EBITDA rose 24% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | ₹44,780 | ||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹196 | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | -₹377 | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 0.4% | ||
| Net Profit Margin | -0.8% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Aarben Biotech Private Limited, buy the company report.
Board of directors of Aarben Biotech Private Limited
Aarben Biotech has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Meena Pandey | Director | 06 Aug 2011 | 15 Years 2 Months | As last reported |
| Om Prakash Kushwaha | Director | 02 May 2011 | 15 Years 5 Months | As last reported |
| Birendra Prasad | Director | 02 May 2011 | 15 Years 5 Months | As last reported |
Peer comparison
Aarben Biotech Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (retail trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Valklub Private Limited | ₹44,939 (FY 2021) | Bangalore, Karnataka, India | ||||
| Dexpol Neo Multitrades Private Limited | ₹44,917 (FY 2024) | 3175.0% | Petlawad, Madhya Pradesh, India | |||
| Sabelloid Pharmaceutical Private Limited | ₹44,900 (FY 2024) | -95.0% | New Delhi, Delhi, India | |||
| Visiting Human India Private Limited | ₹44,853 (FY 2021) | Delhi, India | ||||
| Nynbe Multi Business Private Limited | ₹44,815 (FY 2025) | -22.0% | Ahmednagar, Maharashtra, India | |||
| Aarben Biotech Private Limitedthis company | ₹44,780 (FY 2017) | -₹377 | -0.8% | -8.0% | Surat, Gujarat, India | |
| Ekilogram Expo Private Limited | ₹44,768 (FY 2025) | Vadodara, Gujarat, India | ||||
| Addven Solutions Private Limited | ₹44,717 (FY 2023) | -13.0% | Thane, Maharashtra, India | |||
| Woodspoon Veitments Private Limited | ₹44,709 (FY 2025) | 14.0% | Gurugram, Haryana, India | |||
| Purba Vinimay Private Limited. | ₹44,700 (FY 2020) | 5.0% | Kolkata, West Bengal, India | |||
| Rekha Creations Private Limited | ₹44,691 (FY 2016) | 577.0% | Kolkata, West Bengal, India |
To see the full peer comparison of Aarben Biotech Private Limited, buy the company report.
Auditor
Aarben Biotech Private Limited is audited by Habibullah & Co. for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Habibullah & Co. | FY 2017 | 1087C |
Shareholding
The shareholding of Aarben Biotech Private Limited is on record for 3 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Aarben Biotech Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Aarben Biotech Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Aarben Biotech Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Aarben Biotech Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Aarben Biotech Private Limited has 5 board changes on record since 2011: 3 appointments and 2 cessations. The latest: Anil Kumar Singh ceased to be Director on 27 Sep 2014.
Frequently asked questions
Aarben Biotech has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Aarben Biotech was a private limited company based in Surat, Gujarat, India. The company worked in retailers, within the trading industry. It was incorporated on 02 May 2011 and is registered under CIN U24239GJ2011PTC065249. The company has been struck off by the Registrar of Companies and is no longer operational.
Aarben Biotech had 3 directors:
- Meena Pandey - Director
- Om Prakash Kushwaha - Director
- Birendra Prasad - Director
The CIN (Corporate Identification Number) of Aarben Biotech is U24239GJ2011PTC065249. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Aarben Biotech is at Aagam Navkar Appartment K – 204 2nd Floor Behind Sachin Railway Station, Kansad, Surat, Gujarat, India – 394235.
Aarben Biotech was incorporated on 02 May 2011. It is registered with the Registrar of Companies, Ahmedabad.
The latest financial statements of Aarben Biotech on record with the MCA are for the year ended 31 March 2017. Its last annual general meeting was held on 30 September 2017. Year-wise statements from 2015 are in the company report.
Aarben Biotech operated in the trading industry, in the retailers segment. It worked in this industry before it was struck off.
The peers of Aarben Biotech by revenue are Valklub Private Limited, Dexpol Neo Multitrades Private Limited, Sabelloid Pharmaceutical Private Limited, Visiting Human India Private Limited, Nynbe Multi Business Private Limited and 5 more, all in the same principal business activity (retail trading).
Anil Kumar Singh ceased to be Director on 27 Sep 2014. Lalita Agrawal ceased to be Director on 22 Nov 2013. Meena Pandey was appointed as Director on 06 Aug 2011. Aarben Biotech has 5 board changes on record in total.
The compliance status of Aarben Biotech is active non-compliant as of 21 September 2026.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
